VEGFA and cancer: Therefore, we conducted a retrospective study using clinical data obtained from the electronic medical record (EMR) to gain insight into the burden of CTs in an AYA cancer population who received VEGF therapy, comparing these patients to patients exposed to anthracycline therapy, an agent known for its long-term toxicity to the heart.